About Ignota Labs
Ignota Labs is a company based in London (United Kingdom) founded in 2021 by Layla Hosseini-Gerami and Sam Windsor. Ignota Labs has raised $6.9 million across 1 funding round from investors including Montage Ventures, AIX Ventures and Modi Ventures. The company has 6 employees as of October 31, 2024. Ignota Labs offers products and services including SAFEPATH. Ignota Labs operates in a competitive market with competitors including Fagron, RareStone Group, Syntis, Pharmedium and Revelation Pharma, among others.
- Headquarter London, United Kingdom
- Employees 6 as on 31 Oct, 2024
- Founders Layla Hosseini-Gerami, Sam Windsor
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Absoluteai Ltd
- Date of Incorporation 14 Oct, 2021
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.9 M (USD)
in 1 rounds
-
Latest Funding Round
$6.9 M (USD), Seed
Feb 26, 2025
-
Investors
Montage Ventures
& 4 more
-
Employee Count
6
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ignota Labs
Ignota Labs offers a comprehensive portfolio of products and services, including SAFEPATH.
AI model identifies and mitigates drug safety issues in trials.
Funding Insights of Ignota Labs
Ignota Labs has successfully raised a total of $6.9M through 1 strategic funding round. The most recent funding activity was a Seed round of $6.9 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ignota Labs
Ignota Labs has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Montage Ventures, AIX Ventures and Modi Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused growth stage VC firm
|
Locked | Locked | Locked | |
|
Venture capital is provided to AI-powered companies by AIX Ventures.
|
Locked | Locked | Locked | |
|
Modi Ventures is focused on investments in tech-bio convergence.
|
Locked | Locked | Locked |
Investor details for Ignota Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ignota Labs
Investment portfolio details for Ignota Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ignota Labs
Detailed financials for Ignota Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ignota Labs Comparisons
Peer comparison for Ignota Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ignota Labs
Ignota Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fagron, RareStone Group, Syntis, Pharmedium and Revelation Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug compounding services are provided by Fagron.
|
|
| Locked | Locked | Locked |
Provider of network and treatments to individuals and their families affected by rare diseases drugs
|
|
| Locked | Locked | Locked |
Drug compounding services are provided by Syntis in healthcare.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided to healthcare facilities nationwide.
|
|
| Locked | Locked | Locked |
A network of compounding pharmacies is operated nationwide.
|
Detailed competitors of Ignota Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ignota Labs
Complete news archive for Ignota Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ignota Labs
Ignota Labs was founded in 2021 and raised its 1st funding round 4 years after it was founded.
Ignota Labs is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Sam Windsor is the current CEO of Ignota Labs. They have also founded this company.
Ignota Labs is a funded company, having raised a total of $6.9M across 1 funding round to date.
As of Oct 31, 2024, the latest employee count at Ignota Labs is 6.
Ignota Labs is a technology startup in the pharmaceutical sector that provides AI-driven toxicity prediction tools for early-stage drug discovery scientists. Their suite of tools, TOXSCAPE, helps scientists identify and understand safety issues during the drug discovery process, reducing expensive setbacks and delays.
Ignota Labs offers SAFEPATH.
Ignota Labs has 5 investors. Key investors include Montage Ventures, AIX Ventures, Modi Ventures, Blue Wire Capital, and Gaingels.